Reports for MYLAN-NAPROXEN/ESOMEPRAZOLE MR
Brand name
MYLAN-NAPROXEN/ESOMEPRAZOLE MR
Company Name
MYLAN PHARMACEUTICALS ULC
|
Drug Identification Number
02443449 |
Ingredients
ESOMEPRAZOLE NAPROXEN |
Ingredient Strength
20 MG 500 MG |
ATC Code
M01AEM01AE |
ATC Descriptor
ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 60BT | Resolved | 2025-04-15 | 2025-04-23 | 255076 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 60BT | Resolved | 2025-02-19 | 2025-04-15 | 250703 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 60BT | Resolved | 2025-01-15 | 2025-02-19 | 247737 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 60BT | Resolved | 2024-09-17 | 2025-01-07 | 237812 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 60BT | Resolved | 2024-01-30 | 2024-02-29 | 217867 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 60BT | Resolved | 2023-10-03 | 2024-01-10 | 205932 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 60BT | Resolved | 2023-08-29 | 2023-10-03 | 203214 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 60BT | Resolved | 2023-05-01 | 2023-08-29 | 191357 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 60BT | Resolved | 2023-02-14 | 2023-03-27 | 184568 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 60BT | Resolved | 2022-10-19 | 2023-01-10 | 172186 |
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0